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Available online xxxxCerebral abscess following cholesteatomatous otomastoiditis is a life-threatening complication and poses diag-
nostic and therapeutic challenges.We report a case of life-threatening cerebritis and cerebral abscess due to a col-
lection of pus from an aerobic super infections occurring months after the apparent resolution of an otogenic
brain abscess in a 67-year-old immunocompetent Italian female. Two gram-positive anaerobic pathogens were
isolated during secondary neurosurgical procedures and antibiotic treatmentwas adopted to resolve the compli-
cations. Another objective of this study was to review the literature on gram-positive anaerobic pathogens and
brain abscess complications in patients with ﬁstula, and to highlight the importance of short imaging inmonitor-
ing treatment during long-term antibiotic therapy for otogenic brain abscess to avoid abscess recurrence. Isolat-
ing the strain and monitoring response to treatment with magnetic resonance imaging may improve the
prognosis. The study also highlights the need for a close cooperation between infectious disease consultants
and neurosurgeons.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cerebral abscess is a serious complication that requires immediate
recognition and appropriate treatment. Otogenic infection is often the
cause, and the abscess is usually located on the same side of the diseased
ear. The microorganisms most commonly responsible for infection are
Proteus mirabilis, Enterococcus, and Pseudomonas aeruginosa, while
Pneumococcus and Haemophilus are principally responsible for intracra-
nial complications due to chronic otitis [1–3]. Other pathogens such as
anaerobes, which are part of normal ﬂora of the skin and mouth, can
cause infections with high morbidity and mortality if their commensal
relationship is broken (e.g. due to surgery, traumas, poor blood supply
or tissue necrosis). Anaerobic bacteria play an important role in the
etiopathogenesis of cerebral abscess, which usually requires repeated
surgery. They are part of the human indigenous microbiota and are
mainly found in the urinary tract, digestive and upper respiratorytions of interest. No funds were
ntal Biomedicine and Clinical
, University of Palermo, Via del
).
. This is an open access article undersystems and oral cavity. Nevertheless, they are opportunistic pathogens
that can cause numerous endogenous infections and severe inﬂamma-
tory lesions such as abscess [1–8]. In cases of collected abscesses, anaer-
obes are often neglected unless appropriate isolation and culture is
done. The goal of neurosurgery is to evacuate as much pus and infected
debris as possible to avoid the need for repeated surgery and allow in-
travenous antibiotics to work effectively. The goal of infectious disease
specialists is to diagnose and treat nervous system infections and neuro-
logical complications of systemic infections [9–10]. In neurosurgery, it is
important to identify themain pathogens isolated after craniotomy and
ascertain that the drugs given are effective in eradicating the pathogen
in the brain infection site. In the following section the authors present
a case of cerebral infection complicated by dual infection by Prevotella
melaninogenica and Peptococcus anaerobius in a patient who underwent
a neurosurgical procedure to evacuate a left otogenic abscess extending
to the left temporal lobe.
2. Case report
In June 2015, a 67-year-old woman of Italian origin and nationality
with a history of type 2 diabetes mellitus, hypertension and hyperlipid-
emiawas admitted to the Emergency Department of the Paolo Giaccone
University Hospital with aphasia and right-sided hemiplegia, fever andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lymphocytes and 4% monocytes) and serum C-reactive protein level
(CRP) was 45 mg/dl (normal range 0.08–1.5 mg/dl) and there was no
diagnosis of HIV. Five months before admission, the patient had under-
gone a petrosectomy, followed by transtemporal drainage of an
otogenic brain abscess. The surgical procedure was performed in anoth-
er hospital in Eastern Sicily, Italy. Her post-operative coursewas normal.
Signs and symptoms of infection resolved but severe left-sided hearing
loss persisted.
When the patient came to our attention, brain CT and Gd-enhanced
MRI images showed a parenchymal alteration in the left temporal lobe
at the inferior and middle temporal gyrus with intense Gd-
enhancement and brain swelling (Fig.1). These ﬁndings appeared to
be compatible with cerebritis and abscess. Following an evaluation of
clinical and radiological ﬁndings and multidisciplinary consultation,
the patient underwent a neurosurgical-otolaryngology procedure,
with extension of the previous left subtotal petrosectomy, evacuation
of the abscesswith subsequent reconstruction of the ﬂoor of the tempo-
ral fossa, and intradural irrigation with antibiotic solutions. Once com-
pleted, ﬁbrin sealant (Vivostat®) was sprayed on the operative ﬁeld,
in order to prevent CSF leakage [11–15]. During the surgical procedure,Fig. 1. Brain CT andMRI images: a parenchymal alteration in the left temporal lobe is depicted ana yellowish-green, foul-smelling material was aspirated, believed to be
consistent with pyogenic brain abscess. Samples were taken for micro-
scopic examination and culture to identify the strain. The results turned
out to be difﬁcult to interpret, remaining negative until day six. The pa-
tient was started on an empirical antimicrobial regimen of ceftriaxone
[intravenous (iv) 2 g every 12 h], vancomycin (500 mg every 6 h), and
metronidazole (500 mg every 6 h) to pending further microbiological
results. The patient's clinical condition improved over the post-
operative period. On day 5, a CT scan of the brain showed a signiﬁcant
reduction in the area of post-contrast enhancement, indicating that
the intraparenchymal infectious alteration had reduced.
However, after oneweek of treatment the patient became comatose,
with onset of partial seizures in the buccal rhyme and right arm, and hy-
perpyrexia. CT and Gd-enhanced MRI documented the presence of en-
hanced tissue in the left tympanic cavum and in the left temporal
region, suggesting meningoencephalitis in the left parietal-occipital-
temporal and thalamic region. On hospital day 9, Prevotella
melaninogenica and Peptostreptococcus anaerobius were yielded in the
bacterial culture of intraoperative biopsy samples. Conventional
methods for identifying anaerobic species rely on microbiological cul-
ture coupled with biochemical tests for phenotypic species-leveld intense brain swelling is documented in the T2-weightedMRI sequences on the bottom.
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phology and biochemical tests were carried out to identify strains in
clinical isolates [16]. Special potency anaerobic antimicrobial suscepti-
bility disk patterns (vancomycin, kanamycin, colistin), catalase, spot in-
dole, Rapid ANA II system (Remel, Lexena, KS, USA) or Vitek2
(bioMérieux, St. Louis, MO, USA)were used. Susceptibility of the strains
to antibiotics was determined using CLSI breakpoint recommendations
for anaerobes [17,18]. A new combined antibiotic treatment cilastatin/
imipenem (1 g every 8 h iv) plus clindamycin (600 mg every 6 h iv)
in addition to metronidazole was started pending antibiogram results.
We observed a rapid improvement of the patient's clinical condition,
with fever and seizures disappearing just 48 h after the new therapy
was started. The antibiogramdatawere available after 3 days of starting
the second antibiotic therapy regimen, and showed that the Prevotella
isolate was susceptible to clindamycin 0.015, imipenem, and
meropenem MICs of b0.05 μg/ml; the strain was resistant to penicillin
G MICs of ≥1 μg/ml, ciproﬂoxacin and it was a β-lactamase producer.
It showed a MIC to metronidazole of 2 μg/ml. Peptostreptococcus
anaerobius was resistant to amoxicillin and amoxicillin-clavulanic acid,
3 and 6 μg/ml, respectively and susceptible to clindamycin 0.25 μg/ml,
metronidazole 0.05 μg/ml, imipenem 0.06 μg/ml and meropenem
0.25 μg/ml. The last combined antibiotic regimen was switched to met-
ronidazole plus imipenem cilastatin for 4 weeks. The patient recovered
completely after 1 month and was transferred to other hospital for
motor rehabilitation.
3. Discussion
The ﬁrst-line treatment of otogenic brain abscess includes immedi-
ate decompression of the abscess, prompt eradication of the primary
otogenic nidus, and active prevention of abscess recurrence. Otogenic
brain abscesses with intracranial complications are often located adja-
cent to the temporal lobe and cerebellum, with the middle segment of
the temporal lobe and lateral lobe of the cerebellummost highly affect-
ed. In our patient's case, we used the transtemporal approach to drain
the otogenic brain abscess; recently, other approaches to otogenic intra-
cranial abscess have been proposed [19–21]. Cranial and facial bone os-
teomyelitis is usually caused by oral ﬂora that, like in our case, spread
from a contiguous soft-tissue source or from a sinus, ear or dental infec-
tion. In our case, the strains of pathogens isolated suggested that al-
though the patient did not have any documentation following the ﬁrst
operation that showed minimum bone patency, the authors believe
that a ﬁstulawas responsible for the subsequent cerebral infection com-
plication caused by pathogenswhich are normally found in the oral cav-
ity. We observed two challenging anaerobic bacteria in our patient's
case: Prevotella melaninogenica and Peptococcus spp. These microbes
are notoriously difﬁcult to identify microbiologically, and in the last
few years some strains resistant to routinely-used antibiotics have
been prevalent in their antibiotic sensitivity pattern. Prevotella
melaninogenica, previously known by other names including Fusiformis
nigrescens, Bacteroides nigriscens and Bacteroidesmelaninogenicus, it is so
called because producing colonies that become darker and darker the
longer they are incubated (some strains require up to three weeks);
the brown, or less commonly black pigment is due to a haematin deriv-
ative and not to melanin as was originally thought; moreover, the type
of blood used in the preparation of the media culture inﬂuences pig-
mentation [22–25]. Normally found in the oral cavity (especially in peri-
odontal pockets), in the intestine and urinary tracts, Prevotella
melaninogenica has also been isolated from other sites, usually together
with other microorganisms: infections can develop in the oral cavity,
teeth (periodontitis), tonsils, soft tissues, airways, urinary and genital
tract and intestine; also in infected abdominal wounds and cases of
puerperal sepsis. The genus Peptostreptococcus can cause a variety of
infections, including endocarditis and abscesses, and today new
genera being formed from species previously belonging to the
genus Peptostreptococcus: P. stomatis and P. Anaerobius [22–25].Peptostreptococcus spp. is sensitive to a variety of antibiotics: it is always
sensitive to clindamycin and metronidazole which are the drug of
choice, sensitivity to penicillin, chloramphenicol, erythromycin and tet-
racycline varies. Recently Macrolide resistance in Peptostreptococcus
spp. was reported [24]. A percentage of P. anaerobius showed resistance
to amoxicillin-clavulanic acid and rare isolates to clindamycin [17–19].
Treatment of anaerobic infections is complicated by their slow growth
in culture, their polymicrobial nature and their growing resistance to
antimicrobials. Antimicrobial therapy is often the only type of therapy
required, but in some infections it is an important adjunct to drainage
and surgery. Because anaerobes are generally isolated mixed with aer-
obes, the chosen antimicrobial regimen should provide adequate cover-
age of both. Antimicrobials with adequate intracranial penetration
advocated for these infections are: metronidazole, penicillin,
meropenem and chloramphenicol [24–25]. The antimicrobials that are
most effective against anaerobes are: metronidazole, carbapenems
(imipenem, meropenem, doripenem, ertapenem), chloramphenicol,
combinations of a penicillin and beta-lactamase inhibitor (ampicillin
or ticarcillin plus clavulanate, amoxicillin plus sulbactam, piperacillin
plus tazobactam), tigecycline, cefoxitin and clindamycin [25]. In our
case, we initially combined clindamycin and metronidazole although
the use of multiple drugs active against anaerobes is not necessary
and puts the patient at risk for additional drug toxicities. Data and
guidelines do not support the use of two anti-anaerobic drugs in clinical
practice, with two exceptions - Clostridiumdifﬁcile infection and necro-
tizing fasciitis [26]. In our case report, the decision to use both
clindamycin and metronidazole for 8 days was due to susceptibility
data and severity of post-operative complications. Moreover, in our
case we noted an excellent carbapenem synergy, in particular imipenen
cilastatin plus metronidazole, although imipenem is more neurotoxic
than other such as meropemen.
4. Conclusion
Metronidazole's excellent bactericidal activitymakes it an important
component of most antimicrobial regimens for brain abscess, with a
lower incidence of neurotoxicity. Finally, early diagnosis by imaging
studies is extremely important to guide surgical drainage and prevent
permanent neurological sequelae. Recent studies describe advances in
diagnosis and techniques, and a trend for draining brain abscesses via
minimally invasive surgery is emerging. Probably, in the near future, di-
agnosis conﬁrmation and treatment monitoring with magnetic reso-
nance spectroscopy would allow a greater number of patients to be
managed with medical treatment alone.
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